View Item 

Show simple item record

Glucagon-like peptide-1(7–36) amide is a new incretin/enterogastrone candidate
dc.contributor.authorGök. E, R.en_US
dc.contributor.authorFehmann, Hans-Christophen_US
dc.contributor.authorGök. E, B.en_US
dc.date.accessioned2010-06-01T18:50:17Z
dc.date.available2010-06-01T18:50:17Z
dc.date.issued1991-04en_US
dc.identifier.citationGÖKE, R.; FEHMANN, H.-C.; GÖKE, B. (1991). "Glucagon-like peptide-1(7–36) amide is a new incretin/enterogastrone candidate." European Journal of Clinical Investigation 21(2): 135-144. <http://hdl.handle.net/2027.42/72032>en_US
dc.identifier.issn0014-2972en_US
dc.identifier.issn1365-2362en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/72032
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=1647951&dopt=citationen_US
dc.format.extent1071250 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights1991 European Society for Clinical Investigationen_US
dc.titleGlucagon-like peptide-1(7–36) amide is a new incretin/enterogastrone candidateen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelMedicine (General)en_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationum*Department of Physiology and Internal Medicine, University of Michigan Medical School, Ann Arbor, USAen_US
dc.contributor.affiliationotherDepartment of Internal Medicine, Philipps University of Marburg, Germanyen_US
dc.identifier.pmid1647951en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/72032/1/j.1365-2362.1991.tb01802.x.pdf
dc.identifier.doi10.1111/j.1365-2362.1991.tb01802.xen_US
dc.identifier.sourceEuropean Journal of Clinical Investigationen_US
dc.identifier.citedreferenceConlon JM. Proglucagon-derived peptides: nomenclature, biosynthetic relationships and physiological roles. Diabetologia 1988; 31: 563 – 8.en_US
dc.identifier.citedreferenceGÖke R., GÖke B., Richter G., Arnold R. Entero-insulÄre Achse: Der neue Inkretinkandidat Glucagon-like peptide-1(7–36) amid (GLP-1(7–36)amid). Z Gastroenterologie 1988; 26: 715 – 19.en_US
dc.identifier.citedreferenceBell GI, Sanchez-Pescador R., Layborn PJ, Najarian RC. Exon duplication and divergence in the human preproglucagon gene. Nature 1983; 304: 368 – 71.en_US
dc.identifier.citedreferenceWhite JW, Saunders GF. Structure of the human glucagon gene. Nucleic Acids Res 1986; 14: 4683 – 90.en_US
dc.identifier.citedreferenceDrucker DJ. Glucagon and the glucagon-like peptides. Pancreas 1990; 5: 484 – 8.en_US
dc.identifier.citedreferenceMojsov S., Heinrich G., Wilson IB, Ravazzola M., Orci L., Habener J. Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing. J Biol Chem 1986; 261: 11880 – 9.en_US
dc.identifier.citedreferenceNovak U., Wilks A., Buell G., McEwen S. Identical mRNA for preproglucagon in pancreas and gut. Eur J Biochem 1987; 164: 553 – 8.en_US
dc.identifier.citedreferenceDocherty K., Steiner DF. Post-translational proteolysis in polypeptide hormone biosynthesis. Ann Rev Physiol 1982; 44: 625 – 8.en_US
dc.identifier.citedreferenceThim L., Moody AJ. Purification and chemical characterization of a glicentin-related pancreatic peptide (pro-glucagon fragment) from porcine pancreas. Biochim Biophys Acta 1982; 703: 134 – 41.en_US
dc.identifier.citedreferenceYanaihara C., Matsumoto T., Hong YM, Yanaihara N. Isolation and chemical characterization of glicentin C-terminal hexapeptide in porcine pancreas. FEBS Lett 1985; 189: 50 – 6.en_US
dc.identifier.citedreferencePatzelt C., Schiltz E. Conversion of proglucagon in pancreatic alpha cells: the major endproducts are glucagon and a single peptide, the major proglucagon fragment, that contains two glucagon-like sequences. Proc Natl Acad Sci USA 1984; 81: 5007 – 11.en_US
dc.identifier.citedreferenceThim L., Moody AJ. The primary structure of porcine glicentin (proglucagon). Regul Pep 1981; 2: 139 – 50.en_US
dc.identifier.citedreferenceBataille D., Coudray AM, Carlquist M., Rosselin G., Mutt V. Isolation of glucagon-37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno-ileum. FEBS Lett 1982; 146: 73 – 8.en_US
dc.identifier.citedreferenceOrskov C., Holst JJ, Knuhtsen S., Baldissera FGA, Poulsen SS, Vagn Nielsen O. Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas. Endocrinology 1986; 119: 67 – 1475.en_US
dc.identifier.citedreferenceOrskov C., Bersani M., Johnsen AH, Hojrup P., Holst JJ. Complete sequences of glucagon-like peptide-1 from human and pig small intestine. J Biol Chem 1989; 264: 12826 – 9.en_US
dc.identifier.citedreferenceKreymann B., Yiangou Y., Kanse S., Williams G., Ghatei MA, Bloom SR. Isolation and characterization of GLP-1 7–36 amide from rat intestine. FEBS Lett 1988; 242: 167 – 70.en_US
dc.identifier.citedreferenceHolst JJ, Orskov C., Vagn Nielsen O., Schwartz TW. Truncated glucagon-like peptide-1, an insulin releasing hormone from the distal gut. FEBS Lett 1987; 211: 169 – 74.en_US
dc.identifier.citedreferenceSuzuki S., Kawai K., Ohashi S., Mukai H., Yamashita K. Comparison of the effects of various C-terminal and N-terminal fragment peptides of glucagon-like peptide-1 on insulin and glucagon release from the isolated perfused rat pancreas. Endocrinology 1989; 125: 3109 – 14.en_US
dc.identifier.citedreferenceGefel D., Hendrick GK, Mojsov S., Habener J., Weir GC. Glucagon-like peptide-1 analogs: effects on insulin secretion and adenosine 3′,5′-monophosphate formation. Endocrinology 1990; 126: 2164 – 8.en_US
dc.identifier.citedreferenceSeino S., Welsh M., Bell GJ, Cham SJ, Steiner DF. Mutation in the guinea-pig preproglucagon gene are restricted to a specific portion of the prohormone sequence. FEBS Lett 1986; 203: 25 – 30.en_US
dc.identifier.citedreferenceGÖke R., Conlon JM. Receptors for glucagon-like peptide-1 (7–36) amide on rat insulinoma-derived cells. J Endocrinol 1988; 116: 357 – 62.en_US
dc.identifier.citedreferenceGÖke R., Cole T., Conlon JM. Characterization of the receptor for glucagon-like peptide-1(7–36) amide on plasma membranes from rat insulinoma-derived cells by covalent cross-linking. J Mol Endocrinol 1989; 2: 93 – 98.en_US
dc.identifier.citedreferenceGÖke R., Trautmann ME, Haus E., Richter G., Fehmann HC, Arnold R., GÖke B. Signal transmission after GLP-1(7–36) amide binding in RINm5F cells. Am J Physiol 1989; 257: G397 – 401.en_US
dc.identifier.citedreferenceDrucker DJ, Philippe J., Mojsov S., Chick WL, Habener JF. Glucagon-like peptide 1 stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. Proc Natl Acad Sci USA 1987; 84: 3434 – 8.en_US
dc.identifier.citedreferenceUttenthal LO, BlÁzquez E. Characterization of the gastric receptor for truncated glucagon-like peptide-1 in the rat. FEBS Lett 1990; 262: 139 – 41.en_US
dc.identifier.citedreferenceRichter G., GÖke R., GÖke B., Arnold R. Characterization of receptors for glucagon-like peptide-l(7–36) amide on rat lung membranes. FEBS Lett 1990; 267: 78 – 80.en_US
dc.identifier.citedreferenceShimizu I., Hirota M., Ohboshi C., Shima K. Identification and localization of glucagon-like peptide 1 and its receptor in rat brain. Endocrinology 1987; 121: 1076 – 82.en_US
dc.identifier.citedreferenceGÖke R., Richter G., GÖke B., Trautmann M., Arnold R. Internalization of glucagon-like peptide-1(7–36) amide in rat insulinoma cells. Res Exp Med 1989; 189: 257 – 64.en_US
dc.identifier.citedreferenceUttenthal LO, Ghiglione M., George SK, Bishop AE, Polak JM, Bloom SR. Molecular forms of glucagon-like peptide-1 in human pancreas and glucagonomas. J Clin Endocrinol Metabol 1985; 61: 472 – 9.en_US
dc.identifier.citedreferenceVarndell IM, Bishop AE, Sikri KL, Uttenthal LO, Bloom SR, Polak JM. Localization of glucagon-like peptide (GLP) immunoreactants in human gut and pancreas using light and electron microscopic immunocytochemistry. J Histochem Cytochem 1985; 33: 1080 – 6.en_US
dc.identifier.citedreferenceGeorge SK, Uttenthal LO, Ghiglione M., Bloom SR. Molecular forms of glucagon-like peptides in man. FEBS Lett 1985; 192: 275 – 8.en_US
dc.identifier.citedreferenceManaka H., Taniguchi H., Wada K., Takahashi H., Takahashi K., Katagiri T., Sasaki H. Glucagon-like peptide-1 in the rat pancreas. Biomed Res 1987; 8: 1 – 8.en_US
dc.identifier.citedreferenceKauth T., Metz J. Immunohistochemical localization of glucagon-like peptide 1. Use of poly- and monoclonal antibodies. Histochemistry 1987; 86: 509 – 15.en_US
dc.identifier.citedreferenceHan VKM, Hynes MA, Jin C., Towle AC, Lauder JM, Lund PK. Cellular localization of proglucagon/glucagon-like peptide 1 messenger RNAs in rat brain. J Neurosci Res 1986; 16: 97 – 107.en_US
dc.identifier.citedreferenceSasaki H., Manaka H., Taniguchi H., Katagiri T. Distribution and different processing of glucagon-like peptide-1. Can J Physiol Pharmacol 1986; Suppl (Gastrointestinal Hormones), 64: 157.en_US
dc.identifier.citedreferenceHirota M., Shimizu I., Ohboshi C., Nishino T., Shima K. A large molecular form of glucagon-like peptide-1 (GLP-1) immunoreactivity is co-released with glucagon from pancreas by arginine in normal subjects. Clin Chim Acta 1987; 167: 293 – 302.en_US
dc.identifier.citedreferenceShima K., Hirota M., Ohboshi C., Sato M., Nishino T. Release of glucagon-like peptide 1 immunoreactivity from the perfused rat pancreas. Acta Endocrinol (Copenh) 1987; 114: 531 – 6.en_US
dc.identifier.citedreferenceGhiglione M., Uttenthal LO, George SK, Bloom SR. How glucagon-like is glucagon-like peptide-1? Diabetologia 1984; 27: 599 – 600.en_US
dc.identifier.citedreferenceSchmidt W., Siegel EG, Creutzfeldt W. Glucagon-like peptide-1 but not glucagon-like peptide-2 stimulates insulin release from isolated rat pancreatic islets. Diabetologia 1985; 28: 704 – 7.en_US
dc.identifier.citedreferenceBailey CJ, Flatt PR. Glucagon-like peptide 1 and the enteroinsular axis in obese, hyperglycaemia (ob/ob) mice. Life Sci 1987; 40: 521 – 5.en_US
dc.identifier.citedreferenceMojsov S., Weir G., Habener JF. Insulinotropin: glucagon-like peptide 1(7–37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J Clin Invest 1987; 79: 616 – 19.en_US
dc.identifier.citedreferenceOrskov C., Hoist JJ, Nielsen OV. Effect of truncated glucagon-like peptide-1 (proglucagon-(78–107)amide) on endocrine secretion from pig pancreas, antrum, and non-antral stomach. Endocrinology 1988; 123: 2009 – 13.en_US
dc.identifier.citedreferenceShima K., Hirota M., Ohboshi C. Effect of glucagon-like peptide-1 on insulin secretion. Regul Pep 1988; 22: 245 – 52.en_US
dc.identifier.citedreferenceWeir GC, Mojsov S., Hendrick GK, Habener JF. Glucagon-like peptide 1 (7–37) actions on endocrine pancreas. Diabetes 1989; 38: 338 – 42.en_US
dc.identifier.citedreferenceGÖke R., Fehmann HC, Richter G., Trautmann M., GÖke B. Interaction of glucagon-like peptide-1(7–36) amide and somatostatin-14 in RINm5F cells and in the perfused rat pancreas. Pancreas 1989; 4: 668 – 73.en_US
dc.identifier.citedreferenceKreymann B., Ghatei MA, Williams G., Bloom SR. Glucagon-like peptide-1(7–36): A physiological incretin in man. Lancet ii: 1987; 1300 – 4.en_US
dc.identifier.citedreferenceUnger RH, Eisentraut AM. Entero-insular axis. Arch Intern Med 1969; 123: 261 – 6.en_US
dc.identifier.citedreferenceCreutzfeldt W. The incretin concept today. Diabetologia 1979; 16: 75 – 85.en_US
dc.identifier.citedreferenceKomatsu R., Matsuyama T., Namba M., Watanabe N., Itoh H., Kono N., Tarui S. Glucagonostatic and insulinotropic action of glucagon-like peptide 1-(7–36)-amide. Diabetes 1989; 38: 902 – 5.en_US
dc.identifier.citedreferenceKawai K., Suzuki S., Ohashi S., Mukai H., Ohmori H., Murayama Y., Yamashita K. Comparison of the effects of glucagon-like peptide-1-(1–37) and -(7–37) and glucagon on islet hormone release from isolated perfused canine and rat pancreases. Endocrinology 1989; 124: 1768 – 73.en_US
dc.identifier.citedreferenceKlaff LJ, Taborsky GJ. Pancreatic somatostatin is a mediator of glucagon inhibition by hyperglycemia. Diabetes 1987; 36: 592 – 6.en_US
dc.identifier.citedreferenceD'Alessio D., Fujimoto W., Ensick JW. Effects of glucagonlike peptide 1 (7–36) on release of insulin, glucagon, and somatostatin by rat pancreatic islet cell monolayer cultures. Diabetes 1989; 38: 1534 – 8.en_US
dc.identifier.citedreferenceShima K., Ohboshi C., Hirota M. Effect of glucagon-like peptide 1 (GLP-1) antibodies on glucose-induced insulin secretion in rats. Biomed Res 1989; 10: 417 – 22.en_US
dc.identifier.citedreferenceZawalich W. Synergistic impact of cholecystokinin and gastric inhibitory polypeptide on the regulation of insulin secretion. Metabolism 1988; 37: 778 – 81.en_US
dc.identifier.citedreferenceAhren B., Hedner P., Lundquist I. Interaction of gastric inhibitor polypeptide (GIP) and cholecystokinin (CCK-8) with basal and stimulated insulin secretion in mice. Acta Endocrinol 1983; 102: 96 – 102.en_US
dc.identifier.citedreferenceFehmann HC, GÖke B., Weber V., GÖke R., Trautmann ME, Richter G., Arnold R. Interaction of glucagon-like peptide-1 (7–36) amide and cholecystokinin-8 in the endocrine and exocrine rat pancreas. Pancreas 1990; 5: 361 – 5.en_US
dc.identifier.citedreferenceFehmann HC, GÖke B., GÖke R., Trautmann ME, Arnold R. Synergistic stimulatory effect of glucagon-like peptide-1 (7–36) amide and glucose-dependent insulin-releasing polypeptide on the endocrine rat pancreas. FEBS Lett 1989; 252: 109 – 12.en_US
dc.identifier.citedreferenceFehmann HC, GÖke R., GÖke B., Arnold R. Priming effect of glucagon-like peptide 1 (7–36) amide, glucose-dependent insulin releasing polypeptide and cholecystokinin-8 on insulin secretion from the isolated perfused rat pancreas. Biochim Biophys Acta, 1991 ( in press ).en_US
dc.identifier.citedreferenceTaparel D., Susini CH, Esteve JP, Diaz J., Cazaubon C., Vaysse N., Ribet A. Somatostatin analogues: correlation of receptor affinity with inhibition of cyclic AMP formation in pancreatic acinar cells. Peptides 1985; 6: 109 – 14.en_US
dc.identifier.citedreferenceRichter G., GÖke R., GÖke B., Arnold R. Dexamethasonepretreatment of rat insulinoma cells decreases binding of glucagon-like peptide 1 (7–36) amide. J. Endocrinology 1990; 126: 445 – 50.en_US
dc.identifier.citedreferenceWeber V., Fehmann HC, GÖke R., GÖke B. Effect of proglucagon-derived peptides on amylase release from rat pancreatic acini. Int J Pancreatol, 1991 ( in press ).en_US
dc.identifier.citedreferenceGhiglione M., Blazquez E., Uttenthal LO, De Diego JG, Alvarez E., George SK, Bloom SR. Glucagon-like peptide-1 does not have a role in hepatic carbohydrate metabolism. Diabetologia 1985; 28: 920 – 1.en_US
dc.identifier.citedreferenceShimizu I., Hirota M., Ohboshi C., Shima K. Effect of glucagon like peptide-1 and -2 on glycogenosis in cultured rat hepatocytes. Biomed Res 1986; 7: 431 – 6.en_US
dc.identifier.citedreferenceHoosein NM, Gurd RS. Human glucagon-like peptides 1 and 2 activate rat brain adenylate cyclase. FEBS Lett 1984; 178: 83 – 6.en_US
dc.identifier.citedreferenceMommsen TP, Andrews PC, Plisetskaya EM. Glucagon-like peptides activate hepatic gluconeogenesis. FEBS Lett 1987; 219: 227 – 32.en_US
dc.identifier.citedreferencePlisetskaya EM. Pancreatic peptides. In: Holmgren S., ed. Comparative physiology of regulatory peptides. London: Chapman and Hall, 1989; 174 – 201.en_US
dc.identifier.citedreferenceOttolenghi C., Puviani AC, Gavioli ME, Fabbri E., Brighenti L., Plisetskaya EM. Metabolic action of salmon glucagon and glucagon-like peptide on catfish hepatocytes. Fish Physiol Biochem, ( in press ).en_US
dc.identifier.citedreferencePuviani AC, Ottolenghi, Gavioli ME, Fabbri E., Brighenti L. Action of glucagon and glucagon-like peptide on glycogen metabolism of trout isolated hepatocytes. Comp Biochem Physiol 1990; 96B: 387 – 91.en_US
dc.identifier.citedreferencePlisetskaya EM. Glucagon and related peptides (an overview). Progr Comp Endocrinol, Progress in Clin & Biol Res 1990; 342: 67 – 72.en_US
dc.identifier.citedreferenceMommsen TP, Moon TW. Metabolic action of glucagon-family hormones in liver. Fish Physiol Biochem 1989; 7: 279 – 88.en_US
dc.identifier.citedreferenceConlon JM. Biosynthesis of regulatory peptides: evolutionary aspects. In: Holmgren S., ed. Comparative physiology of regulatory peptides. London: Chapman and Hall, 1989; 344 – 69.en_US
dc.identifier.citedreferenceSchjoldager BTG, Mortensen PE, Christiansen J., Orskov C., Holst JJ. GLP-1 (glucagon-like peptide 1) and truncated GLP-1, fragments of human proglucagon, inhibit gastric acid secretion in humans. Dig Dis Sci 1989; 34: 703 – 8.en_US
dc.identifier.citedreferenceHansen AB, Gespach CP, Rosselin GE, Holst JJ. Effect of truncated glucagon-like peptide 1 on cAMP in rat gastric glands and HGT-1 human gastric cancer cells. FEBS Lett 1988; 236: 119 – 22.en_US
dc.identifier.citedreferenceWalsh JH. Peptides as regulators of gastric acid secretion. Annu Rev Physiol 1988; 50: 41 – 63.en_US
dc.identifier.citedreferenceEissele R., Koop H., Arnold R. Effect of glucagon-like peptide-1 on gastric somatostatin and gastrin secretion in the rat. Scand J Gastroenterol 1990; 25: 449 – 54.en_US
dc.identifier.citedreferenceBrubaker PL, So DCY, Drucker DJ. Tissue-specific differences in the levels of proglucagon-derived peptides in streptocotozin-induced diabetes. Endocrinology 1989; 124: 3003 – 9.en_US
dc.identifier.citedreferenceJacobs LR, Bloom SR, Dowling RH. Response of plasma and tissue levels of enteroglucagon immunoreactivity to intestinal resection, lactation and hyperphagia. Life Sci 1988; 29: 2003 – 7.en_US
dc.identifier.citedreferenceBloom SR, Pollak JM. Trophic influences in the gut. In: SR Bloom, JM Pollak, E. Lindenlaub, eds. Systemic role of regulatory peptides. Stuttgart: Schattauer, 1982; 221 – 7.en_US
dc.identifier.citedreferenceYoshimoto S., Hirota M., Ohboshi C., Shima K. Identification of glucagon-like peptide-1 (7–36) amide in rat brain. Ann Clin Biochem 1989; 26: 169 – 71.en_US
dc.identifier.citedreferenceJin SLC, Han VKM, Simmons JG, Towle AC, Lauder JM, Lund PK. Distribution of glucagon-like peptide 1 (GLP-1), glucagon and glicentin in the rat brain: an immunocytochemical study. J Comp Neurol 1988; 271: 519 – 32.en_US
dc.identifier.citedreferenceKreymann B., Gathei MA, Burnet P., Williams G., Kanse S., Diani AR, Bloom SR. Characterization of glucagon-like peptide 1 (7–36) amide in the hypothalamus. Brain Res 1989; 502: 325 – 31.en_US
dc.identifier.citedreferenceDrucker DJ, Mojsov S., Habener JF. Cell-specific posttranslational processing of preproglucagon expressed from a metallo-thionein-glucagon fusion gene. J Biol Chem 1986; 261: 9637 – 43.en_US
dc.identifier.citedreferenceKanse SM, Kreymann B., Ghattei MA, Bloom SR. Identification and characterization of glucagon-like peptide 1 (7–36) amide binding sites in the rat brain and lung. FEBS Lett 1988; 241: 209 – 12.en_US
dc.identifier.citedreferenceHoosein NM, Gurd RS. Human glucagon-like peptide 1 and 2 activate rat brain adenylate cyclase. FEBS Lett 1984; 178: 83 – 6.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1365-2362.1991.tb01802.x.pdf
Size:
1.021MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.